/stocks — the workspaceLOADING
Strata Critical Medical, Inc. (SRTA) is a services-health services company. Piotroski F-Score 4/7. 11 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-08-04 from SRTA's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
FY ending 2025-12-31 vs 2024-12-31. original 1968 formula; calibrated on manufacturers, read financials/REITs with care
eight-variable model; a screen for earnings-quality review, not an accusation
A plain-English read on SRTA plus an auto-SWOT — built from SRTA's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate SRTA using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
| Third Point (Dan Loeb) | $20.9M | 1.0% of portfolio |
| Wunsch Scott MCEO, Logistics | SELL | $33K | view → |
| Tomkiel Melissa M.Co-CEO and General Counsel | SELL | $175K | view → |
| Cohen AmirChief Accounting Officer | SELL | $27K | view → |
| Heyburn William A.Co-CEO and CFO | SELL | $186K | view → |
| Cohen AmirChief Accounting Officer | SELL | $299K | view → |
| Cohen AmirChief Accounting Officer | SELL | $83K | view → |
Projected from SRTA's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment SRTA files its announcement.
SRTA has rallied after 3 of its last 3 earnings reports.
Large earnings reactions have been common.
SRTA has traded higher after most recent earnings releases.
A more typical earnings reaction has been approximately ±10.8%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-05-06 | +10.8% |
| 2026-03-03 | +8.9% |
| 2025-11-10 | +13.8% |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.